FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - FRA:FME - DE0005785802 - Common Stock
40.54 EUR
+0.92 (+2.32%)
Taking everything into account, FME scores 5 out of 10 in our fundamental rating. FME was compared to 31 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. FME is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
In the past year FME had a positive cash flow from operations.
In the past 5 years FME has always been profitable.
In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.10%, FME is in line with its industry, outperforming 48.39% of the companies in the same industry.
FME's Return On Equity of 4.95% is in line compared to the rest of the industry. FME outperforms 45.16% of its industry peers.
The Return On Invested Capital of FME (3.84%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.75%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
Looking at the Profit Margin, with a value of 3.36%, FME is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
In the last couple of years the Profit Margin of FME has declined.
Looking at the Operating Margin, with a value of 7.15%, FME is in line with its industry, outperforming 58.06% of the companies in the same industry.
In the last couple of years the Operating Margin of FME has declined.
FME has a Gross Margin (24.67%) which is in line with its industry peers.
FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FME is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FME has less shares outstanding
Compared to 1 year ago, FME has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.15 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
FME's Altman-Z score of 2.15 is fine compared to the rest of the industry. FME outperforms 61.29% of its industry peers.
The Debt to FCF ratio of FME is 5.47, which is a neutral value as it means it would take FME, 5.47 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.47, FME is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
A Debt/Equity ratio of 0.71 indicates that FME is somewhat dependend on debt financing.
FME's Debt to Equity ratio of 0.71 is fine compared to the rest of the industry. FME outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.68
WACC5.68%
2.3 Liquidity
A Current Ratio of 1.44 indicates that FME should not have too much problems paying its short term obligations.
The Current ratio of FME (1.44) is better than 74.19% of its industry peers.
A Quick Ratio of 1.08 indicates that FME should not have too much problems paying its short term obligations.
FME has a better Quick ratio (1.08) than 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
The earnings per share for FME have decreased by -0.08% in the last year.
Measured over the past years, FME shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.43% on average per year.
The Revenue has decreased by -0.61% in the past year.
The Revenue has been growing slightly by 2.04% on average over the past years.
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
3.2 Future
The Earnings Per Share is expected to grow by 13.70% on average over the next years. This is quite good.
FME is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.96% yearly.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
FME is valuated correctly with a Price/Earnings ratio of 12.59.
Based on the Price/Earnings ratio, FME is valued cheaper than 80.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.07, FME is valued a bit cheaper.
FME is valuated reasonably with a Price/Forward Earnings ratio of 9.79.
Compared to the rest of the industry, the Price/Forward Earnings ratio of FME indicates a rather cheap valuation: FME is cheaper than 90.32% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (34.08), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 9.79 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than 70.97% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.81 | ||
| EV/EBITDA | 10.5 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as FME's earnings are expected to grow with 13.44% in the coming years.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.51%.
Compared to an average industry Dividend Yield of 2.44, FME pays a better dividend. On top of this FME pays more dividend than 96.77% of the companies listed in the same industry.
FME's Dividend Yield is a higher than the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
FME pays out 64.37% of its income as dividend. This is not a sustainable payout ratio.
FME's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP64.37%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/21/2025, 5:36:15 PM)
40.54
+0.92 (+2.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.79B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Analysts65.6
Price Target49.48 (22.05%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-4.31%
EPS NQ rev (1m)8.29%
EPS NQ rev (3m)6.47%
EPS NY rev (1m)0.52%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.59 | ||
| Fwd PE | 9.79 | ||
| P/S | 1.22 | ||
| P/FCF | 11.81 | ||
| P/OCF | 8.64 | ||
| P/B | 1.79 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.5 |
EPS(TTM)3.22
EY7.94%
EPS(NY)4.14
Fwd EY10.22%
FCF(TTM)3.43
FCFY8.47%
OCF(TTM)4.69
OCFY11.58%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.69
PEG (5Y)N/A
Graham Number40.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.15 |
F-Score6
WACC5.68%
ROIC/WACC0.68
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.09%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 12.59 and the Price/Book (PB) ratio is 1.79.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.